GAVI, THE VACCINE ALLIANCE

Similar documents
GAVI, THE VACCINE ALLIANCE

Gavi Alliance Strategy : Goal level indicators and disease dashboard

GAVI, THE VACCINE ALLIANCE

Gavi s private sector engagement approach

Gavi Secretariat Update: Progress, priorities and strategies

Rotavirus Vaccine. Supply and Procurement Roadmap. The Market Shaping Goal. Public Summary. Rotavirus Supply and Procurement Roadmap UPDATE 2016

GAVI Alliance Demand-side Innovation Policies

TODAY S VACCINATION ECOSYSTEM STATUS MARKET-SHAPING PRINCIPLES, PRACTICE, IMPACT AND LESSONS LEARNT GAVI PERSPECTIVE

Measles Containing Vaccines. UNICEF Supply Division Industry Consultation Meeting January 2012

Gavi s strategic framework 22 June 2016

Gavi, the Vaccine Alliance - Health System and Immunisation Strengthening (HSIS) Support Framework

The use of total funds channelled through "la Caixa" to Gavi programmes in 2017

Gavi initiatives for improving vaccine supply

VACCINE MARKETS OVERVIEW SESSION

Report to the. GAVI Alliance Board June 2013

1. The World Bank-GAVI Partnership and the Purpose of the Review

Gavi Risk Appetite Statement Version 2.0

WHO Update Tania Cernuschi & Patrick Lydon

GAVI s Financing for Pneumococcal Vaccines, including the Advance Market Commitment

Access to vaccination in GAVI countries and at global level

Gavi s Sustainability and Transition Approach

Perspectives on Ensuring Access to Vaccines in Lower Income Countries

Report to the. GAVI Alliance Board June 2014

Market Update. Human Papillomavirus vaccine (HPV) Vaccine Industry Consultation November 2016

innovative finance The GAVI Matching Fund A public-private partnership to save children s lives

The power of innovation to save lives

Update from Gavi, the Vaccine Alliance

GAVI ALLIANCE: UPDATE AND FUTURE DIRECTIONS FOR GLOBAL VACCINES AND IMMUNISATIONS

GAVI Alliance. Aurelia Nguyen, Director Policy & Market Shaping. IPC Meeting 30 May 2013

COLD CHAIN EQUIPMENT OPTIMISATION PLATFORM (CCEOP)

Innovative Finance: the power of innovation to save lives

The power of partnership: the GAVI Alliance Board

Saving lives through immunisation A Corporate Social Responsibility approach

RAPID DIAGNOSIS AND TREATMENT OF MDR-TB

Fifth report of Committee A

innovative finance The GAVI Matching Fund A public-private partnership to save children s lives

Presentation to 13th Annual General Meeting of the DCVMN UNICEF Vaccine Forecasting

Report to the Board 6-7 June 2018

WFP and the Nutrition Decade

Inaugural Keynote Lecture: Contributions of Gavi and DCVMN to the global vaccine markets

Catalytic Framework to End AIDS, TB and Eliminate Malaria in Africa by 2030

Report to the Board June 2016

Executive Board of the United Nations Development Programme, the United Nations Population Fund and the United Nations Office for Project Services

SUCCESSFULLY TRANSITIONING NIGERIA FROM GAVI SUPPORT

Global Health Policy: Vaccines

Ex post evaluation Tanzania

UPDATE ON GAVI. Julian Lob-Levyt. Global Immunisation Meeting New York, February 2009

Cancer prevention and control in the context of an integrated approach

Polio and routine immunisation Alan Brooks

REPRODUCTIVE, MATERNAL, NEWBORN AND CHILD HEALTH (RMNCH) GLOBAL AND REGIONAL INITIATIVES

Harnessing the power of vaccines using the public and private sector: A 21 st century model for international development

Overview of Measlescontaining. through UNICEF. Overview of [VACCINE] through UNICEF

Resolution adopted by the General Assembly. [without reference to a Main Committee (A/62/L.39 and Add.1)]

Strengthening efforts to improve access to and affordability of medicines and technologies in the prevention and control of NCDs

COMMUNICATION ON ENGAGEMENT Reporting on MI s engagement with the private sector

Yellow Fever Vaccine

39th Meeting of the UNAIDS Programme Coordinating Board Geneva, Switzerland. 6-8 December 2016

UNICEF Procurement Advancements DCVMN Annual Meeting Hanoi, Vietnam October 2013

MARKET UPDATE: ROUTINE VACCINE INTRODUCTIONS PCV HPV ROTA

Summary of Definitions of Mission and Strategic Goal Level Indicators. in GAVI Alliance Strategy Updated October 2013

The road towards universal access

Report to the Board June 2016

IMMUNIZATION IN HUMANITARIAN RESPONSE and PARTNER COORDINATION. GAVI Board - 13 June 2017, Geneva

Managing constrained vaccine supply: prevention and remediation Lessons learned and ways forward DVCMN Annual Meeting October Bangkok,

The Strategy Development Process. Global Fund and STOP TB Consultation Istanbul, Turkey 24 July 2015

UNICEF Strategic Plan,

For Health Worldwide Financing Gavi, the Vaccine Alliance as an investment in the future

What is to be done to respond to country needs and comply with WHA and SAGE recommendations?

Improving Health Outcomes Through NCD Prevention. Webinar February 21, 2018

GAVI Secretariat response to the IFFIm evaluation

Update from the GAVI Alliance Seth Berkley, MD Chief Executive Officer

UN HIGH-LEVEL MEETING ON TB KEY TARGETS & COMMITMENTS FOR 2022

FISCAL YEAR 2020 APPROPRIATIONS REQUESTS (updated ) USAID Global Health Programs (GHP) and State Department

2018 INFUSE CALL FOR INNOVATION

Procurement Strategy for Rotavirus and Pneumococcal Conjugate Vaccines. Supplier meeting UNICEF Supply Division 3-4 April 2008 Ann Ottosen

Expanded Programme on Immunization

Information for Access

SPEAKING NOTES OF H.E. DR. AARON MOTSOALEDI, MINISTER OF HEALTH OF REPUBLIC OF SOUTH AFRICA AT THE GLOBAL HIV

Cost-effectiveness, Affordability, and Financing of Cervical Cancer Prevention

The Investment Framework

The Financial Sustainability of New Vaccine Introduction in the Poorest Countries :

The Economic and Social Council, Recalling the United Nations Millennium Declaration13 and the 2005 World Summit Outcome, 1

TOGETHER Quick start guide for

HPV Vaccine Lessons Learned & New Ways Forward

ADVOCACY IN ACTION TO ACHIEVE GENDER EQUALITY AND THE SUSTAINABLE DEVELOPMENT GOALS IN KENYA

Global Collaboration on Cervical Cancer Prevention

GAVI Role in IPV Introductions

5 th Islamic Conference of Health Ministers. Resolution. Istanbul, Turkey November 2015 (5-7 Safar 1437H)

INVESTING IN A NEW FINANCING MODEL FOR THE SUSTAINABLE DEVELOPMENT ERA

Gavi, the Vaccine Alliance: Supply and Procurement Strategy

Action plan for the health sector response to viral hepatitis in the WHO European Region

Report to the GAVI Alliance Board 7-8 July 2011

Pentavalent Market. UNICEF/UN074464/Lister. UNICEF SUPPLY DIVISION 2018 Vaccine Industry Consultation

TYPHOID CONJUGATE VACCINE SUPPORT WINDOW

Report to the Board June 2015

WHO VACCINE SUPPLY & QUALITY SUPPORT FOR NATIONAL IMMUNIZATION PROGRAMMES

INTERNAL QUESTIONS AND ANSWERS DRAFT

WHO Strategy and Goals for Viral Hepatitis Elimination

ARE Position Paper: Women and Sustainable Energy

TALKING POINTS INTRODUCTION

Transcription:

#vaccineswork GAVI, THE VACCINE ALLIANCE Partnerships for Health Outcomes Susan Brown July, 2017, New York Gavi/2012/Doune Porter www.gavi.org

1 ABOUT GAVI Gavi s mission: to save children s lives and protect people s health by increasing equitable use of vaccines in lowerincome countries Gavi/2013/Evelyn Hockstein 2 #vaccineswork

This is where you introduce the idea that different immunisation related outcomes require different partnerships, which is why Gavi is a unique PPP GAVI S PARTNERSHIP MODEL Building on the comparative advantages of both public and private partners 3 #vaccineswork

Gavi leverages the comparative advantages of partners to achieve impact UPSTREAM PLANNING INCENTIVES PROCUREMENT OPERATIONS BMGF Gavi UNICEF WHO TACTICS Product innovation Providing financial resources Technical support Regulatory support Programmatically driven demand forecasts Market analytics Strategic vaccine roadmaps Information transparency Negotiating affordable pricing Innovative financing mechanisms or market incentives Tender process execution Manufacturer award Supply chain operations Technical support for country-led programs, introductions, packaging and cold chain capacity

CREATING SHARED VALUE Meeting public health needs while creating opportunities for partners Gavi convenes government, industry and global health and development leaders to: REACH UNDER-SERVED MARKETS IMPROVE EFFICIENCY ENABLE SUSTAINABLE DEVELOPMENT REDUCE WASTE AND COMPLEXITY BUILD CAPACITY

2 GAVI MISSION AND STRATEGIC GOALS 2016-2020 Gavi/2013/Evelyn Hockstein 6 #vaccineswork

Accelerate equitable uptake and coverage of vaccines Increase effectiveness & efficiency of immunisation delivery as integrated part of strengthened health systems To save children s lives and protect people s health by increasing equitable use of vaccines in lowerincome countries Improve sustainability of national immunisation programmes Shape markets for vaccines and other immunisation products 7 #vaccineswork

3 RESULTS What developing countries have achieved with support from Gavi Gavi/2013/Adrian Brooks 8 #vaccineswork

GAVI SUPPORT BRINGS SUCCESS Delivered together by Gavi, the Vaccine Alliance until 2015 million children immunised million future deaths averted* vaccine introductions and campaigns * Projection Source: Gavi, the Vaccine Alliance data as of December 2015. 9 #vaccineswork

4 PARTNERSHIPS Driven by innovation and collaboration, the Alliance is greater than the sum of its parts Gavi/2013/Adrian Brooks 10 #vaccineswork

Reinforce main idea from Slide 3 varied partnerships needed IMPACT THROUGH PARTNERSHIPS and many more partners from the public, civil society and private sectors 11 #vaccineswork

IMPACT THROUGH GOVERNANCE Gavi is the representative of the Global Funding Mechanism on the PMNCH board Gavi and Global Fund share a seat within the international organisations constituency Gavi has a seat in the Investors Group

MARKET SHAPING Gavi brings low-income countries into the mind-set and planning of vaccine manufacturers

Market shaping in action: accelerating Ebola vaccine development Clear signals from Gavi Board on demand for Ebola vaccines Advance purchase commitment to accelerate availability of Ebola vaccines Gavi Board commitment to invest up to USD 300 million for Ebola vaccine procurement encouraged manufacturers to invest in accelerated development of candidate vaccines and begin advanced trials 300,000 doses made available from mid-2016 for use in emergencies and further clinical trials

INNOVATION AND EXPERTISE Supply Chain Data Management Demand Generation

POLITICAL WILL FOR IMMUNISATION 16 Source: MCIA photos (2016) and Gavi (2016)

POLITICAL COMMITMENT TO IMMUNISATION to ensure and facilitate universal access to immunisation by allocating adequate domestic resources and securing new investments to strengthen national immunisation programmes as well as mount strong advocacy campaigns to achieve the Global Vaccine Action Plan goals and overall health care delivery systems.addis Declaration on Immunisation (January 2017) Source: African Union Heads of State Summit (2017) and Gavi 17 (2016)

5 OPPORTUNITIES Integration is one of the principles framing the Alliance s strategy 2016-2020 Gavi/2013/Adrian Brooks 18 #vaccineswork

Reinforce main idea from Slide 3 varied partnerships needed for SDGs, Gavi committed OPPORTUNITIES Expanding and strengthening PARTNERSHIPS to achieve the SDGs 19

THANK YOU www.gavi.org